Request Demo
Recent blog posts
Latest Hotspot
6 min read
Cogent Biosciences, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Cogent Biosciences, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
Helixmith Co., Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Helixmith Co., Ltd, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
BioCryst Pharmaceuticals, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of BioCryst Pharmaceuticals, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
Beijing Mabworks Biotech Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Beijing Mabworks Biotech, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
Ascentage Pharma Group International Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Ascentage Pharma Group International, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
Bavarian Nordic A/S Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Bavarian Nordic A/S, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
Beijing SL Pharmaceutical Co., Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Beijing SL Pharmaceutical Co., Ltd, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
6 min read
Aligos Therapeutics, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Aligos Therapeutics, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
8 min read
Meibomian gland dysfunction Indication Strategy Report 2026: PPAR-gamma, Trials and Deals
23 July 2026
2026 Meibomian gland dysfunction strategy: epidemiology, PPAR-gamma biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Sjögren dry eye disease Indication Strategy Report 2026: BAFF, Trials and Deals
23 July 2026
2026 Sjögren dry eye disease strategy: epidemiology, BAFF biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Ocular cicatricial pemphigoid Indication Strategy Report 2026: FcRn, Trials and Deals
23 July 2026
2026 Ocular cicatricial pemphigoid strategy: epidemiology, FcRn biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Vogt-Koyanagi-Harada disease Indication Strategy Report 2026: IL-23, Trials and Deals
23 July 2026
2026 Vogt-Koyanagi-Harada disease strategy: epidemiology, IL-23 biology, clinical competition, recent deals, unmet need and market attractiveness.